Tag: Type 2 Diabetes Mellitus

1. In this cohort study, glucagon-like peptide-1 receptor agonist (GLP-1RA) use was associated with a higher risk of anterior ischemic ...

1. In this target trial emulation, glucagon-like peptide-1 receptor agonist (GLP-1RA) use was associated with a small increase in the ...

1. In this target trial emulation, initiating a glucagon-like peptide-1 receptor agonist (GLP-1RA) was not associated with higher rates of ...

1. In this randomized controlled trial, biweekly injections of the novel glucagon-like peptide-1 receptor agonist (GLP-1RA) bofanglutide resulted in greater ...

1. In this randomized controlled trial, tirzepatide produced substantially greater reductions in HbA1c, body weight, waist circumference, and BMI than ...

1. Use of glucagon-like peptide-1 (GLP-1) receptor agonists was associated with reduced risk of developing substance use disorders among US ...

Sex-Specific Associations of α-Synuclein Pathology With Tau Accumulation 1. α-synuclein pathology was associated with faster tau accumulation in women than ...

1. In this cohort study, dulaglutide, semaglutide, and tirzepatide demonstrated similar risks of gastrointestinal adverse events (AEs) in adults with ...

1. In patients with type 2 diabetes (T2D), the risk of major adverse cardiovascular events (MACEs) was lowest among patients ...

Click here to read this study in NEJM.  ©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...